Radiogenomics Models for Predicting Prognosis in Locally Advanced Non -Small Cell Lung Cancer Patients Undergoing Definitive Chemoradiotherapy

被引：0
|
作者：
Song, X. [1 ,2 ]
Li, L. [2 ]
Yuan, S. [2 ]
机构：
[1] Shandong Second Med Univ, Sch Clin Med, Weifang, Shandong, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2142
引用
收藏
页码：E66 / E66
页数：1
相关论文
共 50 条
  • [21] Durvalumab improves prognosis of locally advanced non-small-cell Lung Cancer after definitive Radiochemotherapy
    Hecht, Markus
    Gaipl, Udo S.
    Fietkau, Rainer
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (03) : 269 - 271
  • [22] Application of gene polymorphisms to predict the sensitivity of patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy
    Zhao, Yue
    Xie, Yun
    Jia, Dianjun
    Ma, Chiluan
    Wei, Dongdong
    Zhang, Xiaoyu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (06): : 7382 - 7387
  • [23] Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer
    Ito, Hitoshi
    Matsuo, Yukinori
    Ohtsu, Shuji
    Nishimura, Takashi
    Terada, Yasuji
    Sakamoto, Takashi
    Mizowaki, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 274 - 281
  • [24] Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer
    Hitoshi Ito
    Yukinori Matsuo
    Shuji Ohtsu
    Takashi Nishimura
    Yasuji Terada
    Takashi Sakamoto
    Takashi Mizowaki
    International Journal of Clinical Oncology, 2020, 25 : 274 - 281
  • [25] Treatment Efficacy Of Preoperative Chemoradiotherapy For Patients With Locally Advanced Non-small cell Lung Cancer
    Sasaki, T.
    Uehara, S.
    Abe, M.
    Shioyama, Y.
    Nakamura, K.
    Sugio, K.
    Ichinose, Y.
    Hirata, H.
    Honda, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S624 - S625
  • [26] Primary surgery followed by chemotherapy versus definitive concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
    Kiladze, I.
    Kuchava, V.
    Joxadze, N.
    Katselashvili, L.
    Melkadze, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S67 - S67
  • [27] Blood-based biomarker analysis for predicting efficacy of definitive concurrent chemoradiotherapy and durvalumab consolidation in patients with unresectable locally advanced non-small cell lung cancer
    Park, Cheol-Kyu
    Park, Hwa-Kyung
    Oh, Hyung-Joo
    Cho, Hyun-Ju
    Oh, In-Jae
    Kim, Young-Chul
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Definitive chemoradiation for the treatment of locally advanced non-small-cell lung cancer
    Blackstock, A. William
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (26) : 4146 - 4152
  • [29] Blood-based biomarker analysis for predicting efficacy of definitive concurrent chemoradiotherapy and durvalumab consolidation in patients with unresectable locally advanced non-small cell lung cancer
    Park, C-K.
    Cho, H-J.
    Oh, I-J.
    Kim, Y-C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1379 - S1379
  • [30] Palifermin Reduces Dysphagia in Patients with Locally-advanced Unresected Non-small-cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
    Schuette, W.
    Krzakowski, M.
    Massuti, B.
    Otterson, G.
    Lizambri, R.
    Wei, H.
    Berger, D.
    Chen, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S114 - S114
12345